MorphoSys AG (MUC:MOR) MorphoSys Publishes Preclinical Data From MOR103 Program
MorphoSys AG (MUC:MOR) Antibody Shows Ability to Inhibit Disease in an Established RA Model
Companies in the News
European Finance News
Basilea Pharmaceutica AG (VTX:BSLN) Ceftobiprole, A New Anti-mrsa Broad-spectrum Antibiotic, Receives Approval By Swissmedic
Basilea Pharmaceutica AG (VTX:BSLN) Basel, Switzerland, November 13, 2008 - Basilea Pharmaceutica Ltd. announces that ceftobiprole (Zevtera(TM)), the first-in-class anti-MRSA broad-spectrum cephalosporin, has obtained regulatory approval from Swissmedic for the treatment of complicated skin and soft tissue infections including diabetic foot infections.
Day Software Holding AG (VTX:DAYN) Day Presents Interim Report For Third Quarter Of 2008
Day Software Holding AG (VTX:DAYN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
Pronova BioPharma ASA (OSL:PRON) Pronova BioPharma Share Buy Back
Pronova BioPharma ASA (OSL:PRON) Pronova BioPharma ASA (OSE: PRON.OL) ("Pronova BioPharma" or the "company") has on 12 November 2008 purchased 50 000 of its own shares in the market at a price of NOK 20,92 per share and intends to purchase an additional 91 000 shares in the market. After this transaction, the company holds 109 000 shares. Pronova BioPharma ASA has entered into an agreement to sell 200 000 of the company's shares to Per-Oluf Olsen, who will take over as CEO of the company after Tomas Settevik. This sale will be effected once Per-Oluf Olsen has assumed the position of CEO. Following the completion of these transactions, Pronova BioPharma ASA will not hold any of its own shares.
Ad Hoc: Q-Cells SE (FRA:QCE) : Q-Cells Publishes Report As Of 30 September 2008:
Q-Cells SE (FRA:QCE) Q-Cells SE / Interim report / Ad hoc: Q-Cells publishes Report as of 30 September 2008: Ad hoc announcement according to §15 WpHG processed and transmitted by Hugin. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
Metso Corporation (HEL:MEO1V) Valmet Automotive And Fisker Automotive Have Signed The Cooperation Agreement
Metso Corporation (HEL:MEO1V) Valmet Automotive press release on November 13, 2008 at 8.00 a.m.
Actelion Pharmaceuticals Ltd (VTX:ATLN) Actelion's First-in-class Selective S1P1 Receptor Agonist To Enter Phase II Clinical Development
Actelion Pharmaceuticals Ltd (VTX:ATLN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
◂Previous Page
European Finance News Next Page▸
Banking & Finance
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
- NSX Limited (ASX:NSX) Company Update
Social Media
